 BURLINGTON, Mass., July 13, 2021 GLOBE NEWSWIRE -- LeMaitre Vascular, Inc. Nasdaq:LMAT, a provider of peripheral vascular devices, implants and services, today announced the pricing of an underwritten public offering of 1,000,000 shares of its common stock at a public offering price of 54.50 per share. Gross proceeds to LeMaitre from the offering are expected to be approximately 54.5 million before deducting underwriting discounts and commissions and estimated offering expenses payable by LeMaitre. The offering is expected to close on or about July 16, 2021, subject to customary closing conditions. LeMaitre has granted the underwriters of the offering the right for a period of 30 days to purchase up to an additional 150,000 shares of common stock at the public offering price, less underwriting discounts and commissions. 